CTRI/2020/06/026039尚未招募未知
CANCER care in COVID-19 ERAâ?? A prospective survey to study the preferences and perspectives of patients with hematological malignancies in a tertiary cancer care setting in India. (CANCOV SURVEY) - CanCov Survey Study
I0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients under evaluation for a suspected hematological malignancy or with a diagnosis of hematological malignancy (acute and chronic leukemias, lymphomas, myeloma, and others) will be included in the study.
- •2. Patients who are planned for or receiving chemotherapy / immunotherapy / targeted therapy in the OPD, ward, daycare and ICU will be eligible.
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Perspective of cancer patient in COVID-19 pandemicCTRI/2020/10/028438nil
已完成
不适用
Allocating Resources for Cancer Care in Times of the Sars-CoV-2 Outbreak. Health Care ResearchColorectal Cancer (CRC) and Pancreatic Cancer (PaCa)NCT05479292Technische Universität Dresden6,500
已完成
不适用
The Impact of COVID-19 Pandemic on Cancer CareCancerNCT04382495El Zaitoun Specialized Hospital300
Unknown
不适用
COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including BiobankingCOVIDCancerNCT04408339Universitätsklinikum Hamburg-Eppendorf500
已完成
3 期
C-SMART.COVID-19 Prevention and Treatment in Cancer. Arm 3: treatment among cancer patients with moderate COVID-19 infection.CancerACTRN12620000841976Peter MacCallum Cancer Centre3